Reliable measurements of brain atrophy in individual patients with multiple sclerosis

INTRODUCTION: As neurodegeneration is recognized as a major contributor to disability in multiple sclerosis (MS), brain atrophy quantification could have a high added value in clinical practice to assess treatment efficacy and disease progression, provided that it has a sufficiently low measurement...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Brain Behav
Hlavní autoři: Smeets, Dirk, Ribbens, Annemie, Sima, Diana M., Cambron, Melissa, Horakova, Dana, Jain, Saurabh, Maertens, Anke, Van Vlierberghe, Eline, Terzopoulos, Vasilis, Van Binst, Anne‐Marie, Vaneckova, Manuela, Krasensky, Jan, Uher, Tomas, Seidl, Zdenek, De Keyser, Jacques, Nagels, Guy, De Mey, Johan, Havrdova, Eva, Van Hecke, Wim
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2016
Témata:
Methods
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5036437/
https://ncbi.nlm.nih.gov/pubmed/27688944
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.518
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky